Siponimod slowed disability progression in secondary progressive multiple sclerosis
Venetoclax still under review in Europe.
US researchers develop bio-degradable battery powered by melanin.
This week’s news
AZ continues to sell off already marketed drugs.
NICE is reviewing drugs from old Cancer Drugs Fund.
J&J unit hopes to combine Darzalex with other drugs.
Sanofi criticised following failure of Medivation bid.
Irish biotech joins race to find treatment for NASH.
But there are funding problems in UK, Australia and Canada.
AZD3293 gets Fast Track designation.
Daphne Koller joins as new Chief Computing Officer.
Fit4D wants to improve overall medication adherence and patient health.
Sanofi has competition in its bid to acquire cancer specialist
Liver cancer treatment latest earmarked for removal from CDF
Companies to collaborate using ‘rational vaccine design’